Showing results (2231-2240 of 2,287) with videos related to
Sort By:
Pageof 229
Journal of Affective Disorders|September 3, 2013
Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorderLouisa G Sylvia, Edward S Friedman, James H Kocsis, et al.Blood Advances|December 3, 2024
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myelomaAndrew J Yee, Jacob P Laubach, Erica L Campagnaro, et al.Journal of Medicinal Chemistry|May 14, 2013
Discovery of 2-{3-[2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): a β-sparing phosphoinositide 3-kinase inhibitor with high unbound exposure and robust in vivo antitumor activityChudi O Ndubaku, Timothy P Heffron, Steven T Staben, et al.Nature Communications|May 20, 2026
Glucuronidation metabolomic fingerprinting to map host-microbe metabolismNina R Boyle, Josh J Sekela, Mingxun Wang, et al.Journal of Affective Disorders|April 23, 2014
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trialWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.Bioorganic & Medicinal Chemistry Letters|September 9, 2010
Structure-based optimization of pyrazolo-pyrimidine and -pyridine inhibitors of PI3-kinaseSteven T Staben, Timothy P Heffron, Daniel P Sutherlin, et al.Acta Psychiatrica Scandinavica|June 27, 2015
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorderS L McElroy, D E Kemp, E S Friedman, et al.Journal of Clinical Psychopharmacology|December 17, 2014
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE studyWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.The Journal of Pathology|July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibitionWei Zhou, Adrian M Jubb, Karen Lyle, et al.Pageof 229